Provided by Tiger Trade Technology Pte. Ltd.

Aethlon Medical

6.07
-0.0200-0.33%
Post-market: 6.04-0.0300-0.49%17:01 EDT
Volume:28.24K
Turnover:171.39K
Market Cap:9.74M
PE:-0.14
High:6.18
Open:6.02
Low:6.00
Close:6.09
52wk High:39.50
52wk Low:1.41
Shares:1.60M
Float Shares:1.60M
Volume Ratio:0.36
T/O Rate:1.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-42.4608
EPS(LYR):-428.8747
ROE:-160.91%
ROA:-76.69%
PB:1.87
PE(LYR):-0.01

Loading ...

Aethlon Medical Says Shareholders Reject Proposal to Authorize 20,000,000 Preferred Shares

Reuters
·
Oct 06

Aethlon Medical Shareholders Expand Capital Structure Flexibility

TIPRANKS
·
Oct 02

Aethlon Medical Holds Annual Shareholder Meeting

Reuters
·
Oct 02

Analysts Offer Insights on Healthcare Companies: Aethlon Medical (AEMD) and Kyverna Therapeutics, Inc. (KYTX)

TIPRANKS
·
Sep 24

Nasdaq Jumps 400 Points; US Weekly Jobless Claims Fall

Benzinga Earnings
·
Sep 17

Aethlon Medical Announces Merger with North Immunology

TIPRANKS
·
Sep 17

M&A News: Aethlon Medical Stock (AEMD) Rockets 400% After North Immunology Deal to Fight Eczema

TIPRANKS
·
Sep 17

U.S. Stocks on the MOVE-Generac, Jefferies, Aethlon Medical

Reuters
·
Sep 17

Aethlon Medical, North Immunology enter all-stock transaction

TIPRANKS
·
Sep 17

Aethlon Medical Shares Jump 87.4% to $2.68 Premarket After Co Enters Merger Agreement with North Immunology

THOMSON REUTERS
·
Sep 17

Aethlon Medical Agrees All-Stock Merger with North Immunology

Reuters
·
Sep 17

Aethlon Medical: Pre-Merger Aethlon Stockholders to Own About 4.75%, North Immunology Stockholders to Own About 95.25% of Combined Co

THOMSON REUTERS
·
Sep 17

Aethlon Medical - Enters Definitive All-Stock Merger Agreement with North Immunology

THOMSON REUTERS
·
Sep 17

Aethlon Medical - Combined Company Expected to Have Pro Forma Equity Value of $346.50 Mln

THOMSON REUTERS
·
Sep 17

Aethlon Medical Inc - Pre-Merger North Immunology Stockholders Expected to Own Approximately 95.25% of Combined Company

THOMSON REUTERS
·
Sep 17

Aethlon Medical - $180 Mln Private Placement Expected to Fund Operations into Second Half of 2028

THOMSON REUTERS
·
Sep 17

Aethlon Medical & North Immunology Announce Merger to Advance Novel Il-13 X Il-18 Bispecific Antibody for Atopic Dermatitis

THOMSON REUTERS
·
Sep 17

Aethlon Medical - Stockholders to Receive Contingent Value Right for Each Share Held

THOMSON REUTERS
·
Sep 17

Aethlon Medical - Combined Entity to Operate as North Immunology, and Trade Under Ticker Nrtx

THOMSON REUTERS
·
Sep 17

Aethlon Medical Amends CEO, CFO and CMO Deals to Pay Change-in-Control Severance in Lump Sum

Reuters
·
Sep 15